NVS
Price
$101.15
Change
-$0.91 (-0.89%)
Updated
Sep 22, 6:59 PM EST
32 days until earnings call
OGN
Price
$18.25
Change
-$0.33 (-1.78%)
Updated
Sep 22, 6:59 PM EST
48 days until earnings call

Compare predictions NVS vs OGN

Header iconNVS vs OGN Comparison
Open Charts NVS vs OGNBanner chart's image
Novartis AG
Price$101.15
Change-$0.91 (-0.89%)
Volume$370.03K
CapitalizationN/A
Organon & Co
Price$18.25
Change-$0.33 (-1.78%)
Volume$1.22M
CapitalizationN/A
View a ticker or compare two or three
NVS vs OGN Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
NVS vs. OGN commentary
Sep 23, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVS is a StrongBuy and OGN is a Hold.

COMPARISON
Comparison
Sep 23, 2023
Stock price -- (NVS: $101.14 vs. OGN: $18.26)
Brand notoriety: NVS and OGN are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: NVS: 76% vs. OGN: 138%
Market capitalization -- NVS: $213.18B vs. OGN: $4.75B
NVS [@Pharmaceuticals: Major] is valued at $213.18B. OGN’s [@Pharmaceuticals: Major] market capitalization is $4.75B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $522.24B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $80.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVS’s FA Score shows that 3 FA rating(s) are green whileOGN’s FA Score has 2 green FA rating(s).

  • NVS’s FA Score: 3 green, 2 red.
  • OGN’s FA Score: 2 green, 3 red.
According to our system of comparison, NVS is a better buy in the long-term than OGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVS’s TA Score shows that 4 TA indicator(s) are bullish while OGN’s TA Score has 4 bullish TA indicator(s).

  • NVS’s TA Score: 4 bullish, 5 bearish.
  • OGN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, NVS is a better buy in the short-term than OGN.

Price Growth

NVS (@Pharmaceuticals: Major) experienced а -1.45% price change this week, while OGN (@Pharmaceuticals: Major) price change was -6.55% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.88%. For the same industry, the average monthly price growth was -3.23%, and the average quarterly price growth was -0.33%.

Reported Earning Dates

NVS is expected to report earnings on Oct 24, 2023.

OGN is expected to report earnings on Nov 09, 2023.

Industries' Descriptions

@Pharmaceuticals: Major (-1.88% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
A.I.dvisor published
a Summary for NVS with price predictions.
OPEN
A.I.dvisor published
a Summary for OGN with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
NVS($213B) has a higher market cap than OGN($4.75B). NVS has higher P/E ratio than OGN: NVS (28.33) vs OGN (6.30). NVS YTD gains are higher at: 16.374 vs. OGN (-32.211). NVS has higher annual earnings (EBITDA): 17.8B vs. OGN (1.6B). NVS has more cash in the bank: 11.2B vs. OGN (326M). OGN has less debt than NVS: OGN (8.73B) vs NVS (28.3B). NVS has higher revenues than OGN: NVS (53.1B) vs OGN (6.17B).
NVSOGNNVS / OGN
Capitalization213B4.75B4,486%
EBITDA17.8B1.6B1,115%
Gain YTD16.374-32.211-51%
P/E Ratio28.336.30450%
Revenue53.1B6.17B861%
Total Cash11.2B326M3,436%
Total Debt28.3B8.73B324%
FUNDAMENTALS RATINGS
NVS: Fundamental Ratings
NVS
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
10
Undervalued
PROFIT vs RISK RATING
1..100
8
SMR RATING
1..100
60
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
6
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NVSOGN
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
57%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
39%
Bullish Trend 1 day ago
71%
Momentum
ODDS (%)
Bullish Trend 2 days ago
47%
Bearish Trend 1 day ago
62%
MACD
ODDS (%)
Bullish Trend 2 days ago
51%
Bearish Trend 3 days ago
57%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
49%
Bearish Trend 1 day ago
66%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
36%
Bearish Trend 1 day ago
61%
Advances
ODDS (%)
Bullish Trend 3 days ago
46%
Bullish Trend 25 days ago
67%
Declines
ODDS (%)
Bearish Trend 17 days ago
44%
Bearish Trend 1 day ago
70%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 1 day ago
63%
Aroon
ODDS (%)
Bearish Trend 2 days ago
24%
Bearish Trend 1 day ago
55%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DRTS3.280.08
+2.50%
Alpha Tau Medical Ltd
NXPI196.792.79
+1.44%
NXP Semiconductors NV
EFTR0.51N/A
+0.37%
eFFECTOR Therapeutics
BUSE19.15-0.09
-0.47%
First Busey Corp
LPX55.65-1.05
-1.85%
Louisiana-Pacific Corp

NVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVS has been loosely correlated with AZN. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if NVS jumps, then AZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVS
1D Price
Change %
NVS100%
-0.93%
AZN - NVS
52%
Loosely correlated
+1.21%
MRK - NVS
52%
Loosely correlated
-0.37%
SNY - NVS
50%
Loosely correlated
-0.48%
GSK - NVS
46%
Loosely correlated
-0.51%
GILD - NVS
44%
Loosely correlated
-0.35%
More

OGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGN has been loosely correlated with AZN. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if OGN jumps, then AZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGN
1D Price
Change %
OGN100%
-1.72%
AZN - OGN
34%
Loosely correlated
+1.21%
PFE - OGN
32%
Poorly correlated
-0.49%
GRFS - OGN
32%
Poorly correlated
+0.32%
JNJ - OGN
30%
Poorly correlated
-0.72%
GILD - OGN
29%
Poorly correlated
-0.35%
More